PECAM1 and neoplasm: Consistent with this, JZL184-mediated dose-dependent tumor regression in A549 xenograft athymic nude mice was associated with decreased numbers of CD31-positive cells and upregulation of TIMP-1-positive cells in xenograft tissue.